|
|
|
|
2005 Conference
|
6th Winter Conference Steamboat
Springs, Colorado Saturday, January 22, 2005 Registration packets may be picked up beginning at 1:00 pm until 6:00 pm at the Conference Registration desk located on the Ballroom level of the Sheraton Steamboat Springs. Web
Booklet - PDF Files to Presentations Sunday, January 23, 2005 Registration opens from 1:00 pm to 5:00 pm 5:00 8:00 pm Organic Synthesis in Non-classical Media, Michael VanNieuwenhze, University of California, San Diego, Program Chair Paul Grieco, Montana State University Organic Synthesis in Water and Other Polar Media: An Overview Hartmuth Kolb, The Scripps Research Institute - 'In Situ' Click Chemistry: Enzyme Inhibitors Made to Their Own Specifications Shu Kobayashi, Tokyo University Lewis Acid Catalysis in Aqueous Media 8:00 10:00 pm Monday, January 24, 2005 7:00 am 8:00 11:00 am Blockbuster Drug Symposium, sponsored by Celgene, Les Mitscher, University of Kansas, Program Chair Andy Bell, Pfizer Global Research & Development - The Viagra Story Dale Kempf, Abbott Laboratories - The Kaletra-Ritonavir Story David Wustrow, Pfizer Global R & D - The Neurontin Story 4:00 8:00 pm Cascade Chemistry, Victor Snieckus, Queens University, Program Chair Victor Snieckus, Cascade Chemistry Reactions: An Overview Richard Heck, Cobalt and Palladium Reagents in Organic Synthesis: The Discovery and the Early Years Masahiro Miura, Osaka University - Transition Metal Catalyzed Sequential Coupling via C-H Bond Cleavage Tom Kieboom, Leiden University - Concepts of Nature in Organic Synthesis:
Cascade Catalysis and Multistep Conversions in Concert Ei-ichi Negishi, Purdue University - Tandem and Cascade Carbon-Carbon Bond-Forming Processes Catalyzed by Pd and Zr Complexes Tuesday, January 25, 2005 7:00 am 8:00 11:00 am Solid-supported Reagents, Tony Barrett, Imperial College, Program Chair David Bergbreiter, Texas A&M University - Soluble Polymers as Easily Separable Supports in Synthesis and Catalysis Paul Hanson, University of Kansas - ROM-Polymerization Strategies for Facilitated Synthesis Steve Ley, Cambridge University Development of New Methods for Organic Synthesis John Parlow, Pfizer Global Research & Development Polymer-Assisted Solution-Phase (PASP) Chemical Library Synthesis and its Application on the Tissue Factor VIIa Project 4:00 6:00 pm Poster Session, Bryan Norman, Eli Lilly & Company, Program Chair 11:00 pm 12:30 am Wednesday, January 26, 2005 7:00 am 8:00 11:00 am General Oral Papers I, Dennis Dean, Merck Research Labs, Program Chair
Wayne Brouillette, University of Alabama at Birmingham Design and development of low toxicity UAB-rexinoids for breast cancer chemoprevention Robert Meissner, Merck Research Laboratories, - In vitro and In vivo of a ketone-containing avb3 integrin antagonist for the treatment for osteoporosis William Kinney,
Johnson & Johnson Computational and pharmacokinetic studies directed at
understanding the differences in oral bioavailability seen between closely
related aVb3
integrin antagonists Katherina Leftheris, Bristol Myers Squibb Progression of a novel class of orally active p38 map kinase inhibitors Axel Neffe, University of Canterbury Synthesis and modelling studies of peptidomimetic aldehydes related to a cataract preventing calpain inhibitor Shawn Stachel, Merck Research Laboratories Structure-based design of a series of potent and selective cell permeable inhibitors of human b-secretase 12:00 noon Group Photo at Picnic Area 2:00 pm 6:00 pm Dr. Chris Lipinski, Pfizer Global Research & Development - Chemistry quality and the medicinal chemistry - biology interface 7:00 pm Thursday, January 27, 2005 7:00 am 8:00 11:45 am Protein Conformational Plasticity in Drug Design, Dan Flynn, Deciphera Pharmaceuticals, LLC, Program Chair Dan Erlanson, Sunesis, Inc. - Drug Discovery at Adaptive Signaling Interfaces Betsy Goldsmith, University of Texas Southwestern Medical Center, Dallas Binding sites and conformational changes in protein kinases Tim Willson, GlaxoSmithKline Exploiting Plasticity in Nuclear Receptor Drug Discovery Steven LaPlante, Boehringer Ingelheim Exploiting ligand and receptor adaptability in antiviral drug design 5:00 8:00 pm Small Molecule Modulation of Protein-Protein Interactions, Peter Toogood, Pfizer Global Research & Development, Program Chair Dale Boger, The Scripps Research Institute Targeting protein-protein and protein-DNA interaction using solution phase combinatorial chemistry Lance Stewart, deCODE Genetics, Inc. The Poisoning of Human Topoisomerase I by Structurally Diverse Anticancer Compounds and Various Insults to DNA Jim Wells, Sunesis, Inc. - Challenges for Drug Discovery at Protein/Protein Interfaces David Rees, Astex Technology Ltd. - Starting Small and Strong: Fragment Based Drug Discovery Friday, January 28, 2005 7:00 am 8:00 11:00 am General Oral Papers II, Philippe Nantermet, Merck Research Labs, Program Chair Neville Anthony, Merck Research Laboratories Development of a potent HIV-1 integrase inhibitor with a unique resistance profile Charles Didier, Imperial College Double oxidation of tryptophanes: Synthesis of the potent anthelmintic pyrrolobenzoxazine CJ-126621 Theresa Williams, Merck Research Laboratories Calcitonin gene-related peptide antagonists Robb Webb, Arena Pharmaceuticals APD 356, A potent and selective 5HT2C agonist is a potential new treatment for obesity Birgit Masjost, Roche Diagnostics Structure-based optimization of novel azepane derivatives as PKB selective inhibitors Thomas Ruckle, Serono Pharmaceutical Research Institute Identification and development of potent and selective PI3Kỷ inhibitors Kirk Stevens, GlaxoSmithKline Unusual heterocycle synthesis: Routes to Pyrazolo[1,5-a]Pyridine compounds as P38 kinase inhibitors |
|
|
The Medicinal and Bioorganic Chemistry
Foundation © 2000-2004 Medicinal and Bioorganic Chemistry Foundation |